Oppositional Defiant Disorder | Defiant Teenager | Defiant Kid | ADHD

Back to ADHD News List

ADHD Patch Daytrana methylphenidate Transdermal System Effective In Patients Converted From Oral Long Acting Methylphenidate

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that its Attention Deficit Hyperactivity Disorder (ADHD) patch DAYTRANA? (methylphenidate transdermal system) is effective in patients converted to the patch from efficacious doses of their previous oral long-acting methylphenidate. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif. [click link for full article]

Source: http://www.medicalnewstoday.com/sections/adhd/

In schools, treatment plans are often poorly integrated. In addition, there are few special education funds directed specifically for ADHD
 

This page is about Attention deficit hyperactivity disorder (ADHD)